Introduction
Cervical cancer was the third most common cancer on both incidence and mortality for females, accounting for 9% (529, 800) of the total new cancer cases and 8% (275, 100) of the total cancer deaths among females (Jemal et al., 2011) . Epidemiological observations had established an aetiological association between human papillomavirus (HPV) infection and cervical cancer (Liu et al., 2011) . However, only a small percentage of infected women would finally develop into cervical cancer (Barbisan et al., 2012) . Therefore, a hypothesis can be made here that genetic factors and host immune response are also involved in the progression of cervical precancerous lesions to invasive cervical cancer (Yang et al., 2012; Zhang et al., 2013) .
Interleukin-6 (IL-6), an important pro-inflammatory cytokine, is a multifunctional protein principally involved in the genesis and maintenance of the inflammatory response (Hamaguchi et al., 2011; Ma et al., 2011; Mosaad et al., 2012; Tao et al., 2012; Crosbie et al., 2013) . The human IL-6 gene is organized into five exons and four introns and maps to the short arm of chromosome 7 4 (7p21) (Bowcock et al., 1988) . The IL-6 gene presents two biallelic polymorphisms at positions -174 and -572 in its promoter region (Huang et al., 1999; Bennermo et al., 2004) . It had been found that IL-6 promoter polymorphisms (-174G/C and -572G/C) were associated with various risks of cancers (Xu et al., 2011; Magalhaes et al., 2013) . It was recently suggested that the IL-6 gene polymorphisms at positions -174 and -572 might increase the risk of gynecological malignancies, including cervical cancer (Nogueira de Souza et al., 2006; Castro et al., 2009; Gangwar et al., 2009; Shi et al., 2013) . Therefore, we aimed to evaluate the association of the IL-6 gene polymorphisms at positions -174 and -572 with predisposition to cervical cancer in a Chinese population.
Materials and Methods

Study population
The present hospital-based case-control study comprised 518 patients with cervical cancer and 518 healthy controls between February 2011 and October 2013 in the International Peace Maternity and Child Health Hospital of China Welfare Institute (IPMCH) and
7358
Fudan University Shanghai Cancer Center (FUSCC). Healthy female controls were recruited when they were attending a clinic for routine examination. All cases were histopathologically confirmed as primary cervical cancer independently by two gynecologic pathologists. For the cases, clinical and pathological information was extracted including tumor histology, International Federation of Gynecology and Obstetrics (FIGO) stage, tumor size (the largest tumor diameter of the primary tumor), pelvic lymph node metastasis, lympho-vascular space invasion, depth of cervical stromal invasion and the expression of estrogen receptor and progesterone receptor. All individuals were interviewed by trained nurse-interviewers using a structured questionnaire that detailed their age, body mass index (BMI) and menopausal status. The Ethical Committee of the IPMCH approved the study protocols. And all participants also provided written informed consents according to the Declaration of Helsinki.
DNA extraction and genotyping
The commercially available Qiagen kit (QIAGEN Inc., Valencia, CA, USA) was used to extract DNA from peripheral blood leukocytes. A single base pair (bp) polymorphism at -174 and -572 in the promoter region of the IL-6 gene was analyzed by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The polymorphic region containing the NlaIII restriction site at position -174 base pairs from the transcription start site (a 198-bp PCR fragment of the IL-6 promoter region) was amplified as previously described (Fishman et al., 1998) . The polymorphic region containing the BsrBI restriction site at position -572 base pairs from the transcription start site was amplified using the following primers: 5´-AGATTCCAAGGGTCACTTG-3´ and 5´-AGAAGCAGAACCACTCTTC-3´ (a 519-bp PCR fragment of the IL-6 promoter region). A 5% random sample was reciprocally tested by different persons and the reproducibility was 100%.Ś
tatistical analysis
The allele and genotype frequencies of IL-6 gene in patients were compared to healthy controls' by Chisquared test. The Hardy-Weinberg equilibrium was tested for goodness-of-fit of chi-square test with one degree of freedom to compare the observed genotype frequencies among the subjects with the expected genotype frequencies. The Statistical Analysis System software (Version 8; SAS Institute Inc., Cary, NC, USA) was used to perform all of the statistical analysis. Comparisons between groups were made with χ 2 test (nominal data) or Student t-test (interval data). The p value less than 0.05 was considered statistically significant.
Results
Characteristics of participants
Characteristics of cervical cancer cases and healthy controls were showed in Table 1 . No significant differences were found between the cervical cancer cases and healthy controls on age, body mass index (BMI), and menopausal status (Table 1) . Other information about cervical cancer patients was also provided.
IL-6 -174 G/C polymorphisms and cervical cancer
Patients with cervical cancer had a significantly higher frequency of IL-6 -174 CC genotype (OR=1.52, 95% CI = 1.06-2.19; p=0.02) and IL-6 -174 C allele (OR=1.21, 95% CI=1.02-1.44; p=0.03) than healthy controls (Table  2) . When stratifying by the FIGO stage, patients with III-IV cervical cancer had a significantly higher frequency of IL-6 -174 CC genotype (OR=1.64, 95% CI=1.04-2.61; P=0.04) ( Table 3) . DOI:http://dx.doi.org/10.7314/APJCP.2014.15.17.7357 Relationships between Interleukin-6 Gene Polymorphisms and Cervical Cancer Risk in Chinese 
IL-6 -572 G/C polymorphisms and cervical cancer
Patients with cervical cancer had a significantly higher frequency of IL-6 -572 CC genotype (OR=1.91, 95% CI=1.16-3.13; p=0.01) than healthy controls. When stratifying by the menopausal status, histology, FIGO stage, tumor size, pelvic lymph node, lympho-vascular space invasion, depth of cervical stromal invasion, estrogen receptor expression and progesterone receptor expression of cervical cancer, no obvious statistical association was found (Table 4) .
Discussion
This study provided an evidence for a role of genetic factors in the development of cervical cancer. A metaanalysis of thirteen studies with 1, 936 cases and 2, 858 controls indicated that the methylenetetrahydrofolate reductase (MTHFR) 677T allele might enhance the risk of cervical cancer in the Asian female population and played a protective role in Caucasian females . A meta-analysis of fifteen studies with a total of 3, 743 cervical cancer cases and 4, 096 controls suggested that tumor necrosis factor alpha (TNF-alpha) 308 G/A polymorphism was associated with increased risk of cervical cancer, and TNF-alpha 308 G/A mutant allele A was a risk factor of cervical cancer (Zhang et al., 2013) . A meta-analysis of eight studies suggested that the genetic polymorphism in IL-10-592C/A was a risk factor for developing cervical cancer, especially for Asians (Ni et al., 2013) . A meta-analysis of twentyeight case-control studies suggested that p53 codon 72 polymorphisms might be associated with increased risk of cervical cancer, especially among Indians (Zhou et al., 2012) . A meta-analysis of 21 case-control studies provided strong evidence that the GSTM1 genotype was associated with the development of cervical cancer, especially in smokers, and Chinese and Indian populations (Zhang et al., 2012a) . A meta-analysis including 13 studies suggested that the Arg194Trp polymorphism of x-ray repair crosscomplementing protein 1 (XRCC1) increased the risk of cervical cancer (Shuai et al., 2012) .
IL-6 promoter polymorphisms were also associated with various cancers risks. A systematic review and meta-analysis of 7 studies inferred that IL-6 -174G/C polymorphism was associated with an increased prostate cancer risk (Zhang et al., 2012b) . A meta-analysis involving 29, 377 cases and 37, 739 controls believed that IL-6-174G/C polymorphism was associated with bladder cancer risk (Xu et al., 2011) . A case-control study suggested that IL-6 -174G/C polymorphism was associated with the risk of squamous cell esophageal cancer (Upadhyay et al., 2008) . A study from the Southwestern United States reported that IL-6 -174G/C polymorphism was associated with breast cancer risk (Slattery et al., 2008) . A case-control study informed that IL-6 -174G/C polymorphism was strongly associated with oral cancer risk (Vairaktaris et al., 2006) . A study surmised that the IL-6 -174G/C polymorphism might serve as an additional prognostic parameter in patients with vulvar cancer (Grimm et al., 2005) . A case-control study from Spain assumed that IL-6 -174G/C polymorphism was associated with colorectal cancer risk (Landi et al., 2003) .
However, it is still unclear that what is the association or molecular mechanism between IL-6 promoter polymorphisms (-174G/C and -572G/C) and the risk of cervical cancer. It is well-known that host immune response and chronic inflammation play critical roles on preventing the progression of cervical cancer (Shi et al., 2013) . IL-6, an important pro-inflammatory cytokine, is a multifunctional protein principally involved in the genesis and maintenance of the inflammatory response (Kyo et al., 2000; Srivani et al., 2003; Shi et al., 2013) . There is local production of IL-6 in cervicovaginal secretions. And the production of IL-6 was believed to be related to the severity of cervical neoplasia (Tjiong et al., 1999) . Substantially high microenvironmental IL-6 levels promoted tumor angiogenesis and the development of cervical cancer (Wei et al., 2001a) . IL-6 regulated the mcl-1 expression via a PI 3-K/Akt-dependent pathway that might facilitate the oncogenesis of human cervical cancer by modulating the apoptosis threshold (Wei et al., 2001b) . It was reported that IL-6 -174G/C polymorphism could affect the transcription rate of a reporter gene in transient transfection studies, which could be associated with the different IL-6 responses to stressful stimuli (Fishman et al., 1998) . In table 5, previous studies about the association between IL-6 -174G/C and cervical cancer risk were summarized, which indicated that ethnicities or region differences might be an important influential factor. On the other hand, relative studies were not systematic with small sample size. The paradox of final results was existed between our study and the study from Shi TY's study (Shi et al., 2013) . Considering the relative data of GG genotype as reference only came from 1 case in sub-study 1 and 3 cases in sub-study 2, so the final analysis on GC and CC was not convincing. Some limitations of this study should be noted. First of all, these results should be interpreted with caution because the population was only from China, which reduced the possibility of confounding from ethnicity, so it did not permit extrapolation of the results to other ethnic groups. Secondly, it was the lack of routine HPV screening. We did not have enough information on other risk factors, especially HPV infection, which could be potential confounder. At last, this was a two hospitalbased case-control study, so the selection bias was not avoidable and the subjects might not be representative for the general population.
In conclusion, the CC genotype of the IL-6 gene polymorphisms at positions -174 and -572 may confer a high risk of cervical cancer. Additional studies with detailed HPV infection data are warranted to validate our findings.
